TITLE

Analysis of curative effect of fluoxetine and escitalopram in the depression treatment based on clinical observation

AUTHOR(S)
Zhang Xiaoling; Han Yunping; Lian Yingdong
PUB. DATE
May 2018
SOURCE
Pakistan Journal of Pharmaceutical Sciences;2018 Special Issue, Vol. 31, p1115
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Depression is a common affective disorder or mood disorder, which seriously affects people's physical and mental health and the quality of life. This study compared efficacy of escitalopram and fluoxetine on depression patients, and analyzed the inflammatory factors, serum homocysteine (Hcy) levels and the effects of adverse reactions, so as to provide reference for the clinical. The results showed that the total effective rate of the observation group (90.7%) was higher than that of the control group (80%), but the difference was not statistically significant (p>0.05). The total score of Hamilton Depressive Scale (HAMD) and mood in the observation group was significantly lower than that in the control group after treatment. To sum up, escitalopram and fluoxetine are effective in the treatment of depressive patients, but escitalopram can significantly improve the patient's micro inflammation and depressive symptoms.
ACCESSION #
129935661

 

Related Articles

  • Escitalopram.  // AHFS Consumer Medication Information;Sep2020, p1 

    Escitalopram is used to treat depression and generalized anxiety disorder (GAD; excessive worry and tension that disrupts daily life and lasts for 6 months or longer). Escitalopram is in a class of antidepressants called selective serotonin reuptake inhibitors (SSRIs). It works by increasing the...

  • Combination therapy more effectively induces remission of major depressive disorder.  // JAAPA: Journal of the American Academy of Physician Assistants (;Jun2010, Vol. 23 Issue 6, p53 

    The article reports on a study which found that combination therapy with mirtazapine and other antidepressant medications is more effective than just fluoxetine for achieving remission of major depression.

  • A controlled comparison of flupenthixol and amitriptyline in depressed outpatients. Young, J.P.R; Hughes, W.C.; Lader, M.H. // British Medical Journal;5/8/1976, Vol. 1 Issue 6018, p1116 

    Investigates the amitriptyline or flupenthixol treatment on depressed patients under double-blind procedures. Consideration on the treatment procedures; Developments on patients after treatments; Absence of distinct characteristics of drug effectivity.

  • Treatment of depression in chronic fatigue syndrome.  // American Family Physician;6/1/1996, Vol. 53 Issue 8, p2653 

    Reports on a study by J.H. Vercoulen, et al, published in `Lancet' which evaluated the effectiveness of fluoxetine in the treatment of depression linked with chronic fatigue syndrome. Indication of lack of beneficial effect of fluoxetine on chronic fatigue syndrome.

  • Effects of escitalopram on symptoms and quality of life in patients with allergic rhinitis. Erkul, Evren; Cingi, Cemal; Özçelik Korkmaz, Müge; Çekiç, Tuğba; Çukurova, Ibrahim; Yaz, Aytekin; Erdoğmuş, Nagehan; Bal, Cengiz // American Journal of Rhinology & Allergy;Sep/Oct2012, Vol. 26 Issue 5, p142 

    Background: Insufficient response to treatment and declining quality of life illustrate the continuing need to find new treatment modalities for allergic rhinitis (AR). The purpose of this study was to assess how escitalopram affects symptoms and quality of life among AR patients. Methods: This...

  • Prozac: What's in it for you? McAuliffe, Kathleen // Cosmopolitan;Mar1995, Vol. 218 Issue 3, p208 

    Reports on the physiological effect of prozac, a registered trademark for fluoxetine. Fluoxetine as a drug for mental depression; Prevalence of depression among women; Fluoxetine's indications, derivatives and side effects. INSET: The Prozac blues..

  • Spotlight on the pharmacoeconomics of escitalopram in depression. Croom, Katherine F.; Plosker, Greg L. // CNS Drugs;2004, Vol. 18 Issue 7, p469 

    Unlabelled: Escitalopram (Cipralex), a new highly selective inhibitor of serotonin reuptake, is the active S-enantiomer of RS-citalopram. It is effective in the treatment of patients with major depressive disorder (MDD) and may have a faster onset of therapeutic effect than...

  • Pharmacological means to improve patients' mood. Are they effective and safe? Zylicz, Zbigniew Ben // Medycyna Paliatywna w Praktyce;2016, Vol. 10 Issue 4, p155 

    Low mood and depression can be treated with many non-pharmacological means. However, in terminally ill these means are sometimes insufficient and the doctors need to prescribe drugs. In this article I shall discuss simple and proven drugs that improve patients mood and, some of them do have...

  • ACP guideline: New antidepressants are similarly effective.  // JAAPA: Journal of the American Academy of Physician Assistants (;Feb2009, Vol. 22 Issue 2, p54 

    The article offers guidelines recommended by the American College of Physicians (ACP) in choosing an effective antidepressants to be used in patients with major depressive disorder. Accordingly, the ACP recommends choosing a second-generation antidepressant on the basis of factors other than...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics